MYUNGMOON PHARM CO.,LTD
KOSPI
₩1,242.00
+0.65%
Delayed · cached 15 min
Fair value analysis
017180
MYUNGMOON PHARM CO.,LTD
₩1,242.00
Close used for this calculation
₩977.99Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
24/100
Quality radar
Consensus fair value
₩977.99
Above FV▼ -21.3% against the close used
Model range ₩358.58 – ₩1,947.44
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩358.58Fair value₩977.99Bull₩1,947.44
FairClose
52-week traded range
52W low ₩1,057.0052W high ₩1,945.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
MYUNGMOON PHARM CO.,LTD closed at ₩1,242.00, 27.0% above the consensus fair value of ₩977.99 drawn from 7 valuation models.
Financial DNA score 24/100 — Weak. P/E of 21.8x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩1,068.32
-14.0%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩1,947.44
+56.8%
√(22.5 × EPS × BVPS)
EPS=57, BVPS=2957.14
P/E Fair Value
₩1,140.00
-8.2%
EPS × 20x (sector P/E)
EPS=57, Sector P/E=20x
EV/EBITDA
₩358.58
-71.1%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=10.67B
Book Value (P/B)
₩567.77
-54.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=2957.14, ROE=1.9%, g=3%, r=10%
Reverse DCF
₩1,242.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 8.3% | Historical: 0%
Margin of Safety
₩1,038.94
-16.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=1385.25, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.